Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 288 of 1,261

  1. US 11225460

    Pyrrolidineamide derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  2. US 11225469

    Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  3. US 11224656

    Scintillator nanocrystal-containing compositions and methods for their use

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  4. US 11224655

    Targeting microbubbles

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  5. US 11224646

    Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  6. US 11224647

    Safe potent single platform vaccine against Tier 1 select agents and other pathogens

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  7. US 11224624

    Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and disease

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  8. US 11224630

    Medicinal composition for protection of joints, method for producing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  9. US 11224584

    Sleep apnea treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  10. US 11224577

    Treating infection by a platelet-targeting microbe using nanoparticles

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  11. US 11225483

    Substituted fused pyrrolo-diazepinones and uses thereof

    Northwestern University · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  12. US 11224645

    Glycoconjugate vaccine for leishmaniasis

    The Board of Regents of the University of Texas System · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  13. US 11225514

    Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  14. US 11224595

    Subcutaneous delivery of poly(oxazoline) polymer conjugates

    Serina Therapeutics, Inc. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  15. US 11225477

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  16. US 11224659

    Solid solution compositions and use in severe pain

    Infirst Healthcare Limited · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  17. US 11225641

    Probiotic Bifidobacterium strain

    PrecisionBiotics Group Limited · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  18. US 11219673

    Compositions and methods for delivery of biomacromolecule agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  19. US 11220496

    Compounds and method for treating autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  20. US 11219608

    Triple combination formulation for treatment of chronic pain

    Northwestern University · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  21. US 11220535

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  22. US 11220479

    Glucosylceramide synthase inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  23. US 11219692

    Porphyrin modified telodendrimers

    The Regents of the University of California · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  24. US 11220524

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.